Nk-B inhibitors for the treatment of muscular dystrophy

Details for Australian Patent Application No. 2006249851 (hide)

Owner A. T. Still University of Health Sciences

Inventors Carlson, C. George; Samadi, Abbas

Agent Griffith Hack

Pub. Number AU-A-2006249851

PCT Pub. Number WO2006/127930

Priority 60/762,394 26.01.06 US; 60/684,504 24.05.05 US

Filing date 24 May 2006

Wipo publication date 30 November 2006

International Classifications

A61K 31/365 (2006.01) - Lactones

A61K 31/401 (2006.01) - Proline

A61K 31/635 (2006.01)

A61P 21/00 (2006.01) Drugs for disorders of the muscular or neuromuscular system

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups

Event Publications

31 January 2008 PCT application entered the National Phase

  PCT publication WO2006/127930 Priority application(s): WO2006/127930

22 December 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006249856-Taste potentiator compositions and beverages containing same

2006249847-Crystalline and other forms of 4-amino-5-fluoro-3-[6-(4-methylpiperazi n1-yl)-1H-benzimidazol-2-yl]-1H-quinolin2-one lactic acid salts